© 2020 MJH Life Sciences and AJMC. All rights reserved.
© 2020 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
November 26th 2020, 12:30pm
New real-world data confirms that carfilzomib, lenalidomide, and dexamethasone (KRd) are a safe and effective option for patients with relapsed or refractory multiple myeloma.
November 25th 2020, 4:30pm
November 25th 2020, 3:30pm
Findings published in BMC Ophthalmology suggest that during diagnosis and follow-up of glaucoma with high myopia, more attention ought to be focused on structure and functional defects in macular areas.
November 25th 2020, 1:32pm
The entire year has been dominated by the coronavirus disease 2019 (COVID-19) and many countries in the world are experiencing second or third waves of COVID-19 cases as the weather turns colder. Here, we take an updated look at how this pandemic evolved and progressed thus far in 2020.
November 25th 2020, 1:00pm
Compared with treprostinil, selexipag carried a 47% reduced risk of pulmonary arterial hypertension (PAH)-related hospitalization and 46% reduced risk of all-cause hospitalization.
November 23rd 2020, 5:56pm
Research behind the therapy could lead to other discoveries about heart disease as well as the aging process.
November 23rd 2020, 12:30pm
Most patients who are diagnosed with acute myeloid leukemia are in middle or old age. The relatively small number who are diagnosed earlier in life can be subject to long-term health risks due to their treatment.
November 21st 2020, 4:10pm
Authors in the Journal of Clinical Oncology discuss hypotheses on the differences in mutations and implications for treatment with PARP inhibitors.
November 21st 2020, 1:30pm
Using DIXON, T2 mapping, and diffusion tensor imaging, the researchers obtained quantitative MRI for 31 patients with spinal muscular atrophy (SMA) types 2 and 3.
November 20th 2020, 9:48pm
Mounting evidence is supporting the use of poly ADP-ribose polymerase (PARP) inhibitors in prostate cancer, according to a new study.